Lucinda Tam

2.7k citations
12 papers · 857 indexed · 1 hit paper · h-index 7

Lucinda Tam

11 papers receiving 849 citations

Hit Papers

Cross-tissue organization of the fibroblast lineage5552021202620222024100200300400500

Peers

Lucinda Tam
Comparison fields: 5 of 85
  • Immunology 356
  • Oncology 249
  • Cancer Research 100
  • Genetics 65
  • Immunology and Allergy 34
Replace Christian Cox with:
Christian Cox United States
Aslıhan Karabacak Calviello Germany
Anastasia N. Tikhonova United States
Jessica Tsui United States
Víctor G. Martínez Spain
Mitali Manzur Australia
Hélder Trindade Portugal
Erick P. Chan United States
Joana Campos United Kingdom
Hiromi Sakashita Japan
Lucinda Tam relative to Christian Cox United States Christian Cox's profile →
Citations per field
00.5×
Christian Cox · 1×
Citations per year

Countries citing papers authored by Lucinda Tam

Since Specialization
Citations

This map shows the geographic impact of Lucinda Tam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucinda Tam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucinda Tam more than expected).

Fields of papers citing papers by Lucinda Tam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucinda Tam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucinda Tam. The network helps show where Lucinda Tam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lucinda Tam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lucinda Tam Line = papers co-authored together Lucinda Tam links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 202327
2 20230
3 20222
4 20229
5 20222
6 20226
7
Cross-tissue organization of the fibroblast lineagebreakdown →
2021555
8 202146
9 20207
10 20202
11 201547
12 2005154

About Lucinda Tam

Lucinda Tam is a scholar working on Immunology, Physiology and Immunology and Allergy, having authored 12 papers that have together received 857 indexed citations. Recurring topics across this work include Immune Response and Inflammation (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), CRISPR and Genetic Engineering (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Immune cells in cancer (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), HER2/EGFR in Cancer Research (2 papers) and Occupational exposure and asthma (2 papers). The work is most often cited by research in Immunology (356 citations), Oncology (249 citations) and Cancer Research (100 citations). Lucinda Tam has collaborated with scholars based in United States, France and Palestinian Territory. Frequent co-authors include Merone Roose‐Girma, Zora Modrušan, Shannon J. Turley, Yeqing Angela Yang, Joseph R. Arron, Amber W. Wang, Akshay T. Krishnamurty, Sören Müller, Christian Cox and Matthew B. Buechler. Their work appears in journals such as Nature, SHILAP Revista de lepidopterología and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026